| Financial Year |
March 31 2023 |
| Monetary Funds |
15,109,906,114.81 |
| Held-for-trading Financial Assets |
99,095,403.40 |
| Notes Receivable |
213,776,940.25 |
| Accounts Receivable |
37,928,026,810.18 |
| Advances to Suppliers |
3,878,094,807.76 |
| Other Receivables |
3,509,890,059.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,373,368,439.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
73,524,139.79 |
| Other Current Assets |
148,265,020.98 |
| Total Current Assets |
79,567,352,716.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,759,579,964.97 |
| Investment Properties |
1,283,435,813.43 |
| Fixed Assetes |
7,371,639,995.86 |
| Under-construction Projects |
1,049,463,485.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,854,102,627.25 |
| R&D expenses |
160,558,054.61 |
| Goodwill |
800,970,185.31 |
| Long-Term Deferred and Prepaid Expenses |
124,286,309.31 |
| Deferred Income Tax Assets |
521,698,100.22 |
| Other Non-Current Assets |
4,410,393.89 |
| Sub-Total of Non-Current Assets |
16,847,671,256.57 |
| Total Assets |
96,415,023,973.10 |
| Short-Term Loans |
12,576,838,897.62 |
| Trading Financial liabilities |
175,905,755.28 |
| Notes Payable |
24,336,281,283.02 |
| Accounts Payable |
17,482,247,811.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
338,838,515.52 |
| Taxes Payable |
538,088,349.66 |
| Interest Payable |
-- |
| Dividend Payable |
7,940,683.36 |
| Other payables |
4,614,831,749.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,131,334,555.01 |
| Other Current Liabilities |
178,547,855.98 |
| Sub-Total of Current Liabilities |
62,980,209,199.19 |
| Long-term Loans |
3,268,719,916.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
447,315,741.04 |
| Other Non-Current Liabilities |
74,307,582.24 |
| Sub-Total of Non-Current Liabilities |
4,233,764,907.50 |
| Total Liabilities |
67,213,974,106.69 |
| Paid-In Capital(Or Share Stock) |
1,873,869,441.00 |
| Capital Surplus |
8,205,933,091.09 |
| Surplus Reserve |
1,092,843,304.56 |
| LESS:Treasury Stock |
774,238,429.11 |
| Undistributed Profits |
12,418,705,806.71 |
| Minority Stockholder's Interest |
4,003,553,559.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,197,496,306.56 |
| Owner's Equity（Stockholder's Equity） |
29,201,049,866.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
96,415,023,973.10 |
